{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:27:47Z","timestamp":1787923667161,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejogrb.2026.115198","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:43:54Z","timestamp":1779029034000},"page":"115198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["NIPT failure due to excessive chromosomal aberrations in an autoimmune pregnancy"],"prefix":"10.1016","volume":"323","author":[{"given":"Qianzhu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1147-5665","authenticated-orcid":false,"given":"Lin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejogrb.2026.115198_b0005","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/pd.6580","article-title":"Test performance and clinical utility of expanded non-invasive prenatal test: Experience on 71,883 unselected routine cases from one single center","volume":"44","author":"Faieta","year":"2024","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ejogrb.2026.115198_b0010","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.2147\/IJWH.S547427","article-title":"Clinical application of noninvasive prenatal testing in singleton pregnancy with and without in vitro fertilization: a 6-year observational study at a single tertiary center","volume":"17","author":"Zhang","year":"2025","journal-title":"Int J Womens Health"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115198_b0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/pd.6852","article-title":"Clinical implications of noninvasive prenatal testing failures due to low fetal fraction: associations with adverse maternal and fetal outcomes","volume":"45","author":"Ren","year":"2025","journal-title":"Prenat Diagn"},{"issue":"22","key":"10.1016\/j.ejogrb.2026.115198_b0020","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.21.02260","article-title":"Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study","volume":"40","author":"Heesterbeek","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115198_b0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/dna.2017.4112","article-title":"The combining effects of cell-free circulating tumor DNA of breast tumor to the noninvasive prenatal testing results: a simulating investigation","volume":"37","author":"Cai","year":"2018","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115198_b0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/uog.17473","article-title":"Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false-negative cell-free DNA test result for trisomy 21","volume":"51","author":"Ma","year":"2018","journal-title":"Ultrasound Obstetr Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115198_b0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12967-018-1705-2","article-title":"Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure","volume":"16","author":"Dabi","year":"2018","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115198_b0040","article-title":"The impact of maternal autoimmune disease on cell-free DNA test characteristics","volume":"3","author":"MacKinnon","year":"2021","journal-title":"Am J Obstetr Gynecol MFM"},{"key":"10.1016\/j.ejogrb.2026.115198_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.preghy.2020.07.015","article-title":"Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes","volume":"22","author":"Yuan","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2026.115198_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820760","article-title":"Undifferentiated connective tissue disease in pregnancy: a topic yet to be explored","volume":"13","author":"Serena","year":"2022","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115198_b0055","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.fertnstert.2009.08.062","article-title":"Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure","volume":"93","author":"Sauer","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115198_b0060","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.55563\/clinexprheumatol\/c96ief","article-title":"The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes","volume":"39","author":"Schreiber","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115198_b0065","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/1566524016666161013142335","article-title":"Clinical experience of non-invasive prenatal chromosomal aneuploidy testing in 190,277 patient samples","volume":"16","author":"Hu","year":"2016","journal-title":"Curr Mol Med"},{"issue":"47","key":"10.1016\/j.ejogrb.2026.115198_b0070","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.1518151112","article-title":"Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA","volume":"112","author":"Yin","year":"2015","journal-title":"PNAS"},{"issue":"20","key":"10.1016\/j.ejogrb.2026.115198_b0075","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.1321997111","article-title":"Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing","volume":"111","author":"Liao","year":"2014","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115198_b0080","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1038\/s41588-025-02377-x","article-title":"Expanding the scope of non-invasive prenatal screening","volume":"57","author":"Stanley","year":"2025","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115198_b0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/OP.23.00594","article-title":"Comprehensive recommendations for the clinical management of pregnant women with noninvasive prenatal test results suspicious of a maternal malignancy","volume":"20","author":"Heesterbeek","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ejogrb.2026.115198_b0090","article-title":"Effective identification of maternal malignancies in pregnancies undergoing noninvasive prenatal testing","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115198_b0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10238-024-01313-3","article-title":"Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies","volume":"24","author":"Giudice","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ejogrb.2026.115198_b0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","article-title":"The diagnosis and classification of undifferentiated connective tissue diseases","volume":"48\u201349","author":"Mosca","year":"2014","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115198_b0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/uog.13418","article-title":"Repeated failed non-invasive prenatal testing owing to low cell-free fetal DNA fraction and increased variance in a woman with severe autoimmune disease","volume":"44","author":"Hui","year":"2014","journal-title":"Ultrasound Obstetr Gynecol"},{"issue":"49","key":"10.1016\/j.ejogrb.2026.115198_b0110","doi-asserted-by":"crossref","first-page":"E5302","DOI":"10.1073\/pnas.1421126111","article-title":"Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing","volume":"111","author":"Chan","year":"2014","journal-title":"PNAS"},{"issue":"23","key":"10.1016\/j.ejogrb.2026.115198_b0115","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1073\/pnas.1406103111","article-title":"Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing","volume":"111","author":"Yu","year":"2014","journal-title":"PNAS"},{"issue":"17","key":"10.1016\/j.ejogrb.2026.115198_b0120","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1039\/D0AN00813C","article-title":"High-resolution DNA size enrichment using a magnetic nano-platform and application in non-invasive prenatal testing","volume":"145","author":"Zhang","year":"2020","journal-title":"Analyst"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115198_b0125","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/pd.5695","article-title":"Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment","volume":"40","author":"Nakamura","year":"2020","journal-title":"Prenat Diagn"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:44:12Z","timestamp":1787921052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S0301211526002666"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115198","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NIPT failure due to excessive chromosomal aberrations in an autoimmune pregnancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115198"}}